Aspire Private Capital, LLC Bristol Myers Squibb CO Transaction History

Aspire Private Capital, LLC

$385 Million
Q2 2024

A detailed history of Aspire Private Capital, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Aspire Private Capital, LLC holds 5,130 shares of BMY stock, worth $261,219. This represents 0.06% of its overall portfolio holdings.

Number of Shares

5,130

Previous 14,337 64.22%

Holding current value

$261,219

Previous $777,000 72.59%

% of portfolio

0.06%

Previous 0.21%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 15, 2024	SELL	$40.25 - $52.99 $370,581 - $487,878	-9,207 Reduced 64.22%	5,130 $213,000
Q1 2024 Apr 18, 2024	BUY	$47.98 - $54.4 $150,705 - $170,870	3,141 Added 28.05%	14,337 $777,000
Q4 2023 Feb 01, 2024	BUY	$48.48 - $57.85 $378,725 - $451,924	7,812 Added 230.85%	11,196 $574,000
Q3 2023 Nov 03, 2023	SELL	$57.89 - $64.73 $474,408 - $530,462	-8,195 Reduced 70.77%	3,384 $196,000
Q2 2023 Jul 24, 2023	BUY	$63.71 - $70.74 $58,167 - $64,585	913 Added 8.56%	11,579 $740,000
Q1 2023 May 30, 2023	BUY	$65.71 - $74.53 $62,818 - $71,250	956 Added 9.85%	10,666 $739,000
Q1 2023 May 03, 2023	BUY	$65.71 - $74.53 $62,818 - $71,250	956 Added 9.85%	10,666 $739,000
Q4 2022 May 30, 2023	SELL	$68.48 - $81.09 $65,466 - $77,522	-956 Reduced 8.96%	9,710 $698,000
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $116,689 - $138,177	1,704 Added 21.28%	9,710 $698,000
Q3 2022 Nov 10, 2022	BUY	$0.13 - $76.84 $1,019 - $602,732	7,844 Added 4841.98%	8,006 $569,000
Q2 2022 Aug 01, 2022	BUY	$72.62 - $79.98 $2,977 - $3,279	41 Added 33.88%	162 $12,000
Q1 2022 May 10, 2022	SELL	$61.48 - $73.72 $5,471 - $6,561	-89 Reduced 42.38%	121 $9,000
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $1,072 - $1,250	-20 Reduced 8.7%	210 $13,000
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $477,916 - $559,816	-8,077 Reduced 97.23%	230 $14,000
Q2 2021 Aug 09, 2021	BUY	$61.91 - $67.42 $150,998 - $164,437	2,439 Added 41.56%	8,307 $555,000
Q1 2021 May 26, 2021	BUY	$59.34 - $66.74 $11,393 - $12,814	192 Added 3.38%	5,868 $370,000
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $4,445 - $5,038	-77 Reduced 1.34%	5,676 $352,000
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $86,661 - $96,032	1,509 Added 35.56%	5,753 $347,000
Q2 2020 Aug 13, 2020	BUY	$54.82 - $64.09 $133,870 - $156,507	2,442 Added 135.52%	4,244 $250,000
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $7,377 - $10,721	-159 Reduced 8.11%	1,802 $100,000
Q4 2019 Feb 11, 2020	BUY	$49.21 - $64.19 $2,411 - $3,145	49 Added 2.56%	1,961 $126,000
Q3 2019 Nov 12, 2019	BUY	$42.77 - $50.71 $8,810 - $10,446	206 Added 12.08%	1,912 $97,000
Q2 2019 Aug 13, 2019	BUY	$44.62 - $49.34 $12,984 - $14,357	291 Added 20.57%	1,706 $77,000
Q1 2019 May 13, 2019	SELL	$45.12 - $53.8 $75,079 - $89,523	-1,664 Reduced 54.04%	1,415 $68,000
Q4 2018 Feb 25, 2019	BUY	$48.76 - $63.23 $135,113 - $175,210	2,771 Added 899.68%	3,079 $160,000
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $15,018 - $19,474	308 New	308 $160,000

Others Institutions Holding BMY

# of Institutions

2,400

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $108B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspire Private Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspire Private Capital, LLC with notifications on news.

Account

Aspire Private Capital, LLC Bristol Myers Squibb CO Transaction History